Mirabig-S 25 Tablet ER
Marketer
MSN Laboratories
Salt Composition
Mirabegron (25mg) + Solifenacin (5mg)
Overview Mirabig-S 25 Tablet ER
Mirabig-S 25 Extended-Release tablets combine two active ingredients to manage overactive bladder symptoms. This medication provides relief from urinary frequency, urgency, and incontinence. Always follow your physician's instructions regarding dosage and treatment duration. It can be administered with or without food, ideally at the same time daily. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Commonly reported side effects include elevated blood pressure, upper respiratory infection (affecting the nose and throat), urinary tract infections, and headaches. Report any persistent or bothersome side effects to your doctor immediately. Before commencing treatment, disclose all other medications and existing health conditions to your doctor. Pregnant or breastfeeding individuals should inform their physician beforehand. Patients with liver or kidney impairment require careful monitoring and regular check-ups as directed by their doctor.
Uses of Mirabig-S 25 Tablet ER
Symptoms associated with an overactive bladder
Major Benefits of Mirabig-S 25 Tablet ER:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mirabig-S 25 Extended-Release Tablet can be administered with or without food, although consistent timing is recommended.
Common Side effects of Mirabig-S 25 Tablet ER:
- High blood pressure
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Dryness in mouth
- Constipation
- Increased heart rate
- Blurred vision
How to use Mirabig-S 25 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mirabig-S 25 Tablet ER can be administered with or without food; however, consistent daily timing is recommended.
How Mirabig-S 25 Tablet ER works:
Mirabegron and Solifenacin, combined as Mirabig-S 25 ER Tablet, offer dual-action bladder control. Mirabegron, a beta-3 agonist, eases bladder muscle contractions by stimulating specific bladder receptors. Solifenacin, an antimuscarinic agent, achieves similar relaxation through a different mechanism. This synergistic effect reduces urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Mirabig-S 25 Tablet ER concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Data on Mirabig-S 25 Tablet ER use in pregnancy is lacking. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Mirabig-S 25 Tablet ER use while breastfeeding is lacking. Seek your physician's advice.
DrivingCONSULT YOUR DOCTOR
The effect of Mirabig-S 25 Tablet ER on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Mirabig-S 25 Tablet ER use in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Mirabig-S 25 Tablet ER use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Mirabig-S 25 Tablet ER :
NA
Facts to Know About Mirabig-S 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Urologic Care |





